Spleen-based islet transplantation restores glycemic control in type 1 diabetes without full immunosuppression

Wenzhou Medical University researchers have reimagined the spleen as a viable site for islet transplantation, enabling long-term diabetes control without the burden of full immunosuppression. Nanoparticle-driven spleen remodeling allowed transplanted mouse, rat, and human islets to restore normal blood sugar in diabetic rodents and cynomolgus macaques.

Leave A Comment

Your email address will not be published. Required fields are marked *